Acumen Pharmaceuticals Inc
NASDAQ:ABOS

Watchlist Manager
Acumen Pharmaceuticals Inc Logo
Acumen Pharmaceuticals Inc
NASDAQ:ABOS
Watchlist
Price: 1.07 USD -6.14% Market Closed
Market Cap: 64.8m USD

Intrinsic Value

ABOS's intrinsic value estimate is unreliable because it is based only on its DCF value and doesn't use a relative valuation using multiples.

The intrinsic value of one ABOS stock under the Base Case scenario is 3.34 USD. Compared to the current market price of 1.07 USD, Acumen Pharmaceuticals Inc is Undervalued by 68%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ABOS Intrinsic Value
3.34 USD
Undervaluation 68%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Acumen Pharmaceuticals Inc

Valuation History Unavailable

Historical valuation for ABOS cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%
Compare ABOS to

Fundamental Analysis

Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ABOS?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Acumen Pharmaceuticals Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Acumen Pharmaceuticals Inc

Current Assets 154.9m
Cash & Short-Term Investments 149.1m
Receivables 376k
Other Current Assets 5.4m
Non-Current Assets 49.5m
Long-Term Investments 48.8m
PP&E 373k
Other Non-Current Assets 363k
Efficiency

Free Cash Flow Analysis
Acumen Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Acumen Pharmaceuticals Inc

Revenue
0 USD
Operating Expenses
-126.6m USD
Operating Income
-126.6m USD
Other Expenses
10.4m USD
Net Income
-116.3m USD
Fundamental Scores

ABOS Profitability Score
Profitability Due Diligence

Acumen Pharmaceuticals Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

27/100
Profitability
Score

Acumen Pharmaceuticals Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

ABOS Solvency Score
Solvency Due Diligence

Acumen Pharmaceuticals Inc's solvency score is 54/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Negative Net Debt
Low D/E
54/100
Solvency
Score

Acumen Pharmaceuticals Inc's solvency score is 54/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ABOS Price Targets Summary
Acumen Pharmaceuticals Inc

There are no price targets for ABOS.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Acumen Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for ABOS is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

ABOS Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one ABOS stock?

The intrinsic value of one ABOS stock under the Base Case scenario is 3.34 USD.

Is ABOS stock undervalued or overvalued?

Compared to the current market price of 1.07 USD, Acumen Pharmaceuticals Inc is Undervalued by 68%.

Back to Top